Microbion is a pioneer in developing innovative, environmentally responsible products that address the issue of biofilm control, both in health and in industry.
Location: United States, Montana, Bozeman
Total raised: $25M
Founded date: 2000
Investors 2
| Date | Name | Website |
| 02.04.2021 | Cavendish ... | cavendishf... |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.01.2017 | - | $25M | Quark Vent... |
Mentions in press and media 8
| Date | Title | Description |
| 15.03.2022 | Microbion Corporation Announces Granting of a US Patent for the Use of Topical Pravibismane for Diabetic Foot Ulcer Infections | Extends patent protection for Microbion’s proprietary topical pravibismane for the treatment of diabetic foot ulcer infections to 2039 |
| 22.02.2021 | Microbion Corporation Receives Additional Funding Support from the Cystic Fibrosis Foundation to Speed Advancement of Inhaled Pravibismane | – IND-enabling Studies Underway |
| 12.01.2021 | 5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rights | Montreal, Québec and Bozeman, Montana, January 12, 2021 –– 5N Plus Inc. (“5N Plus”), a leading global producer of specialty chemicals and engineered materials, and Microbion Corporation (“Microbion”), a clinical stage pharmaceutical company... |
| 09.01.2017 | Term Sheet — Monday, January 9 | 10X EXIT, CYBER, FASHION Good morning, readers. Some quick notes to kick off your week. It’s a healthy exit for Trello’s investors – sources tell Term Sheet the deal will deliver a multiple of around 10x. The company had raised $10.3 millio... |
| 08.01.2017 | Microbion Raises $25M from Quark Venture | Quark Venture Inc., a Vancouver-based health sciences venture capital company and GF Securities, a leading investment bank in Hong Kong, announced a US$25 million investment in Microbion Corporation through its Global Health Sciences Ventur... |
| 05.01.2017 | Microbion Raises US$25m in Funding | Microbion Corporation, a Vancouver, BC and Bozeman, MT-based clinical stage biopharmaceutical company, raised US$25m in funding. Quark Venture Inc., a Vancouver-based health sciences venture capital firm, made the investment through its Glo... |
| 03.10.2012 | Penn Medicine gets $2.5M grant to evaluate anti-infection treatment in orthopedic surgery | Samir Mehta, chief of the Orthopaedic Trauma & Fracture Service at Perelman School of Medicine said: “Orthopedic trauma and fracture patients are at an increased risk for infection. If successful, this new treatment strategy could be a ... |
| - | Penn Medicine gets $2.5M grant to evaluate anti-infection treatment in orthopedic surgery | Infections are always a concern with surgical procedures. They can lead to longer hospital stays which can not only ramp up healthcare costs but they can also lead to some devastating complications, like amputation. The Perelman School of M... |